Rei Okamoto

1.1k total citations
13 papers, 441 citations indexed

About

Rei Okamoto is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Rei Okamoto has authored 13 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Organic Chemistry and 3 papers in Oncology. Recurrent topics in Rei Okamoto's work include Synthesis and biological activity (2 papers), Biochemical and Molecular Research (2 papers) and Lipid Membrane Structure and Behavior (2 papers). Rei Okamoto is often cited by papers focused on Synthesis and biological activity (2 papers), Biochemical and Molecular Research (2 papers) and Lipid Membrane Structure and Behavior (2 papers). Rei Okamoto collaborates with scholars based in Japan, United States and China. Rei Okamoto's co-authors include Toshihiro Imaeda, Kazuyoshi Aso, Jumpei Aida, Jessica Vincent, Katherine Rothamel, Carolina Adura, J. Fraser Glickman, Yasutomi Asano, Antonio N. Luz and Seth A. Reasoner and has published in prestigious journals such as Nature Communications, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Rei Okamoto

13 papers receiving 440 citations

Peers

Rei Okamoto
Santosh Keshipeddy United States
Lianhu Wei Canada
Ian Loke Australia
Rei Okamoto
Citations per year, relative to Rei Okamoto Rei Okamoto (= 1×) peers Yasutomi Asano

Countries citing papers authored by Rei Okamoto

Since Specialization
Citations

This map shows the geographic impact of Rei Okamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rei Okamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rei Okamoto more than expected).

Fields of papers citing papers by Rei Okamoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rei Okamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rei Okamoto. The network helps show where Rei Okamoto may publish in the future.

Co-authorship network of co-authors of Rei Okamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Rei Okamoto. A scholar is included among the top collaborators of Rei Okamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rei Okamoto. Rei Okamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Zhang, Hao, John D. Ginn, Wenhu Zhan, et al.. (2022). Design, Synthesis, and Optimization of Macrocyclic Peptides as Species-Selective Antimalaria Proteasome Inhibitors. Journal of Medicinal Chemistry. 65(13). 9350–9375. 16 indexed citations
2.
Ginn, John D., Xiuju Jiang, Mayako Michino, et al.. (2021). Whole Cell Active Inhibitors of Mycobacterial Lipoamide Dehydrogenase Afford Selectivity over the Human Enzyme through Tight Binding Interactions. ACS Infectious Diseases. 7(2). 435–444. 5 indexed citations
3.
Okamoto, Rei, Yuji Ishichi, Yasufumi Miyamoto, et al.. (2020). Discovery of 1,8-naphthyridin-2-one derivative as a potent and selective sphingomyelin synthase 2 inhibitor. Bioorganic & Medicinal Chemistry. 28(7). 115376–115376. 9 indexed citations
4.
Takahashi, Masashi, Rei Okamoto, Shinji Morimoto, et al.. (2019). Structure‐Based Design, Synthesis, and Biological Evaluation of Imidazo[4,5‐b]Pyridin‐2‐one‐Based p38 MAP Kinase Inhibitors: Part 2. ChemMedChem. 14(24). 2093–2101. 3 indexed citations
5.
Takahashi, Masashi, Rei Okamoto, Shinji Morimoto, et al.. (2019). Structure‐Based Design, Synthesis, and Biological Evaluation of Imidazo[4,5‐b]pyridin‐2‐one‐Based p38 MAP Kinase Inhibitors: Part 1. ChemMedChem. 14(10). 1022–1030. 6 indexed citations
6.
Zhan, Wenhu, Hao-Chi Hsu, Trevor Morgan, et al.. (2019). Selective Phenylimidazole-Based Inhibitors of the Mycobacterium tuberculosis Proteasome. Journal of Medicinal Chemistry. 62(20). 9246–9253. 15 indexed citations
7.
Vincent, Jessica, Carolina Adura, Pu Gao, et al.. (2017). Small molecule inhibition of cGAS reduces interferon expression in primary macrophages from autoimmune mice. Nature Communications. 8(1). 750–750. 261 indexed citations
8.
Adachi, Ryutaro, Kazumasa Ogawa, Shin-ichi Matsumoto, et al.. (2017). Discovery and characterization of selective human sphingomyelin synthase 2 inhibitors. European Journal of Medicinal Chemistry. 136. 283–293. 23 indexed citations
9.
Fujimoto, Jun, Rei Okamoto, Naoyoshi Noguchi, et al.. (2017). Discovery of 3,5-Diphenyl-4-methyl-1,3-oxazolidin-2-ones as Novel, Potent, and Orally Available Δ-5 Desaturase (D5D) Inhibitors. Journal of Medicinal Chemistry. 60(21). 8963–8981. 18 indexed citations
10.
Okamoto, Rei, Hisaya Kojima, & Manabu Fukui. (2017). Acidocella aquatica sp. nov., a novel acidophilic heterotrophic bacterium isolated from a freshwater lake. INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY. 67(11). 4773–4776. 3 indexed citations
11.
Okamoto, Rei, et al.. (2012). Toward the Total Synthesis of (±)-Andrastin C. The Journal of Organic Chemistry. 78(1). 93–103. 23 indexed citations
13.
Toyota, Masahiro, et al.. (2002). Simple Construction of Bicyclo[4.3.0]nonane, Bicyclo[3.3.0]octane, and Related Benzo Derivatives by Palladium-Catalyzed Cycloalkenylation. Organic Letters. 4(24). 4293–4296. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026